SUBSCRIBERS

QT Vascular enrols first patients for Chocolate Touch study

Add BT as a preferred source

Published Tue, May 19, 2015 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.

In a filing to the Singapore Exchange on Tuesday, the group said it is working closely with local and United States physicians on the study, which will evaluate the clinical utility of the Chocolate Touch PTCA for the treatment of de novo coronary lesions.

QT Vascular

Reuse this content Feedback

TRENDING NOW

Visitors at the KL Tower. Industry observers say inbound trip cancellations have surged to approximately 5,000 in the past month.

Malaysia tourism hit by fuel shock; tour prices may jump 50%

A residential building hit by an air strike in Teheran. Unless Iran collapses, we must foresee that an injured state will renew every effort to rebuild and strike back, says the writer.

The fog of the Iran war

Chinese Foreign Minister Wang Yi stopped short of explicitly naming the US or Israel as aggressors, a telling omission from a country that otherwise speaks with little diplomatic timidity.

Beijing’s calculated silence on the Iran war

Foreign institutional and individual investors trading via licensed platforms in Vietnam will face a 0.1% tax on transaction value.

Vietnam sets low bar for crypto taxes to pull trading onshore

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News